Skip to main content
ADHERIUM LIMITED logo

ADHERIUM LIMITED — Investor Relations & Filings

Ticker · ADR ISIN · AU000000ADR1 ASX Manufacturing
Open in API
Filings indexed 872 across all filing types
Latest filing 2022-11-29 Declaration of Voting R…
Country AU Australia
Listing ASX ADR

About ADHERIUM LIMITED

https://www.adherium.com

Adherium Limited is a digital health company specializing in the development and commercialization of connected medical devices and software solutions for chronic respiratory management. The company's primary offering is the Hailie® platform, which consists of advanced sensors that attach to various inhaler medications to monitor usage and technique. These sensors transmit data via Bluetooth to a mobile application and a cloud-based portal, providing patients and healthcare providers with real-time insights into medication adherence and respiratory health trends. By facilitating remote patient monitoring and data-driven clinical decisions, Adherium aims to improve health outcomes for individuals living with asthma and chronic obstructive pulmonary disease (COPD). The platform is utilized by healthcare systems, pharmaceutical companies, and clinical research organizations to enhance patient engagement and optimize treatment efficacy.

Recent filings

Filing Released Lang Actions
Results of Meeting and Director Update 2 pages 301.3KB
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'RESULTS OF 2022 ANNUAL GENERAL MEETING AND DIRECTOR UPDATE' and provides detailed voting results for resolutions passed at the 2022 Annual General Meeting (AGM) of Adherium Limited. It includes proxy votes, poll votes, and the outcome of each resolution. Additionally, it announces a director stepping down. The document references compliance with ASX Listing Rule 3.13.2 and section 251AA of the Corporations Act, which relate to disclosure of AGM voting results. The content is focused on the official announcement of voting results from the AGM, not the AGM materials or the full annual report. The document length is 3535 characters, which is relatively short and consistent with a voting results announcement rather than a full report. Therefore, the appropriate classification is Declaration of Voting Results & Voting Rights Announcements (DVA).
2022-11-29 English
US FDA clearance of Adherium's Hailie for GSK inhalers 4 pages 365.6KB
Regulatory Filings Classification · 95% confidence The document is a press release announcing that Adherium Limited has received U.S. FDA 510(k) clearance for its inhaler monitoring devices. It discusses regulatory approval, market coverage, and product features but does not contain financial statements, management discussion, or detailed financial data. The document is approximately 7,173 characters long, which is relatively short and typical for an announcement rather than a full report. There is no indication that this is an annual or interim report, audit report, earnings release, or any other detailed financial filing. It is clearly an announcement of a regulatory clearance event and product update. Therefore, the most appropriate classification is Regulatory Filings (RNS), which covers general regulatory announcements and miscellaneous filings that do not fit other categories.
2022-11-27 English
Adherium exhibiting at 2022 BTS Winter Meeting 2 pages 108.2KB
Regulatory Filings Classification · 95% confidence The document is a short announcement about Adherium exhibiting at the 2022 British Thoracic Society Winter Meeting. It describes the event, the company's participation, and its products on display. There is no financial data, no regulatory filing references, no voting results, no management changes, no earnings or annual report content. The document is under 5,000 characters and reads like a press release or event announcement rather than a formal report or filing. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or any other detailed financial or governance report. It is best classified as a Regulatory Filing (RNS) as a general announcement that does not fit other categories.
2022-11-23 English
Adherium SPP and Shortfall Offers Prospectus 41 pages 1.1MB
Capital/Financing Update Classification · 100% confidence The document is a detailed prospectus dated 17 November 2022 for a Share Purchase Plan (SPP) and Shortfall Offers by Adherium Limited. It includes offer details, important dates, terms and conditions, and legal disclaimers. The content focuses on the company's capital raising activities through issuing new shares and options to existing shareholders and investors. There is no financial performance data, earnings information, or management discussion of results. The document is clearly a formal offer to raise capital and not a report or announcement of results. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and detail confirm it is the actual prospectus, not just an announcement of a report publication or a regulatory filing.
2022-11-16 English
Update - Proposed issue of securities - ADR 6 pages 31.6KB
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding a proposed issue of securities by Adherium Limited. It includes details about the securities offer, timetable updates, shareholder approval, and conditions related to the offer. The content focuses on the capital raising activity, including the terms of the securities, offer price, and subscription conditions. There is no financial statement or detailed financial performance data, nor is it a report or transcript. The document is clearly an update on a financing activity, specifically a securities issuance. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length and detail support this classification with high confidence.
2022-11-15 English
Update - Proposed issue of securities - ADR 6 pages 30.4KB
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding a proposed issue of securities by Adherium Limited. It includes details about the offer, timetable, shareholder approval at an Extraordinary General Meeting (EGM), and conditions related to the securities issuance. The content focuses on the update to a previous announcement about the timetable and specifics of the securities offer, including pricing, subscription conditions, and shareholder approvals. There are no financial statements or detailed financial performance data present, and the document is not a full report but an update on capital raising activities. Therefore, this fits the category of a Capital/Financing Update (CAP). The document length (7417 characters) supports it being a detailed announcement rather than a brief notice or a full report.
2022-11-15 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.